Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 7912-7914, December 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bretton, P. R.
Right arrow Articles by Melamed, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bretton, P. R.
Right arrow Articles by Melamed, M. R.

DNA in Situ Sensitivity to Denaturation in Bladder Cancer and Its Correlation with Tumor Stage1

P. R. Bretton, Z. Darzynkiewicz, E. Henry, M. Kimmel, W. R. Fair and M. R. Melamed

Memorial Sloan-Kettering Cancer Center Departments of Pathology [Z. D., E. H., M. K., M. R. M.], and Surgery, Division of Urology [P. R. B., W. R. F.], New York, New York 10021

DNA content and sensitivity of DNA in situ to denaturation by acid were analyzed by flow cytometry of cell nuclei freshly isolated from the bladder tumors of 32 patients and were compared with normal urothelium of 8 subjects. DNA sensitivity to denaturation was assessed in RNase treated cells by acridine orange metachromasia following partial denaturation with hydrochloric acid; the extent of denatured DNA is given as an index ({alpha}t), representing the ratio of single stranded to total DNA per nucleus.

Of the low stage tumors (papillomas, Ta, Tis, T1) 11 of 18 (61%) were aneuploid. Of the high stage tumors (T2 and T3a) 11 of 14 (79%) were aneuploid. DNA in nuclei of normal transitional epithelium was very sensitive to denaturation, as was papilloma, characterized by nuclear {alpha}t indices of 0.73 ± 0.01 (SD) and 0.73 ± 0.04, respectively. Nuclear DNA of noninvasive carcinomas (Ta, Tis) was significantly more resistant to denaturation ({alpha}t = 0.69), and DNA of invasive carcinomas was most resistant, ranging from {alpha}t = 0.61 (T1 tumors) to {alpha}t = 0.59 (T2 tumors) to {alpha}t = 0.57 (T3 tumors).

High stage tumors as a group (T2, T3) had significantly different (lower) {alpha}t values than low stage tumors (Ta, Tis, T1). In model cell culture systems it is known that a decrease in {alpha}t index, i.e., greater resistance to denaturability, occurs as cells transit from resting phase into the cell cycle. Whether the {alpha}t index can be used to estimate resting vesus cycling cells of human tumors is still speculative; changes in DNA denaturability also are known to occur with changes in chromatin structure during cell differentiation and in transformation. However, the empirical relationship between {alpha}t index and tumor stage, of itself, may prove clinically useful in identifying more advanced and perhaps more aggressive tumors.

1 Supported in part by National Cancer Institute Grants R01-CA 14134 and UO-CA 41021.

Received 11/ 6/89. Accepted 9/17/90.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.